130 related articles for article (PubMed ID: 12609809)
1. [Chemoradiotherapy of solid tumours in the adult: current views and perspectives].
Noël G; Mazeron JJ; Favaudon V
Bull Cancer; 2003 Jan; 90(1):85-92. PubMed ID: 12609809
[TBL] [Abstract][Full Text] [Related]
2. [Concurrent chemoradiotherapy update].
Reboul F; Vincent P; Chauvet B; Alfonsi M; Berger C; Serin D
Bull Cancer; 1999 Jan; 86(1):77-83. PubMed ID: 10029709
[No Abstract] [Full Text] [Related]
3. [Update on radiotherapy].
Mazeron JJ
Bull Cancer; 1998 Jan; 85(1):79-82. PubMed ID: 9752356
[No Abstract] [Full Text] [Related]
4. [Chemoradiotherapy. Therapeutic indications: the doctor's point of view].
Natale D; Orlando D
Suppl Tumori; 2004; 3(4):S123-4. PubMed ID: 15206236
[No Abstract] [Full Text] [Related]
5. The combined use of radiotherapy and chemotherapy in the treatment of solid tumours.
Bartelink H; Schellens JH; Verheij M
Eur J Cancer; 2002 Jan; 38(2):216-22. PubMed ID: 11803138
[TBL] [Abstract][Full Text] [Related]
6. [The concomitant use of radiotherapy and chemotherapy for the treatment of solid malignant tumors].
Bartelink H; Schellens JH; Verheij M
Ned Tijdschr Geneeskd; 2002 Mar; 146(11):504-8. PubMed ID: 11925799
[TBL] [Abstract][Full Text] [Related]
7. [Concurrent chemotherapy and radiation therapy for unresectable locally advanced carcinoma of the esophagus. Phase II study and clinical review on literature].
Fritz P; Stoll P; Wannenmacher M; Zierhut D
Strahlenther Onkol; 2003 May; 179(5):328-36. PubMed ID: 12740660
[TBL] [Abstract][Full Text] [Related]
8. Chemoradiation for locally advanced, unresectable NSCLC. New standard of care, emerging strategies.
Gordon GS; Vokes EE
Oncology (Williston Park); 1999 Aug; 13(8):1075-88; discussion 1088, 1091-4. PubMed ID: 10499243
[TBL] [Abstract][Full Text] [Related]
9. [Dose-response relationship in radiotherapy: an evidence?].
Chauvet B; de Rauglaudre G; Mineur L; Alfonsi M; Reboul F
Cancer Radiother; 2003 Nov; 7 Suppl 1():8s-14s. PubMed ID: 15124539
[TBL] [Abstract][Full Text] [Related]
10. [Biological basis for concomitant chemoradiotherapy in carcinomas].
Favaudon V; Noël G
Bull Cancer; 2005 Dec; 92(12):1027-31. PubMed ID: 16396748
[TBL] [Abstract][Full Text] [Related]
11. Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors.
Vokes EE; Weichselbaum RR
J Clin Oncol; 1990 May; 8(5):911-34. PubMed ID: 2185342
[TBL] [Abstract][Full Text] [Related]
12. Accelerated fractionation head and neck intensity-modulated radiation therapy and concurrent chemotherapy in the community setting: safety and efficacy considerations.
Monroe AT; Young JA; Huff JD; Ernster JA; White GA; Peddada AV
Head Neck; 2009 Sep; 31(9):1144-51. PubMed ID: 19340861
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
Budach W; Hehr T; Budach V; Belka C; Dietz K
BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
[TBL] [Abstract][Full Text] [Related]
14. [Exclusive medical management for curative treatment of squamous cell carcinoma of the esophagus: radiotherapy, chemoradiotherapy].
Mornex F; Calais G
Gastroenterol Clin Biol; 1999 May; 23(5):513-8. PubMed ID: 10429855
[No Abstract] [Full Text] [Related]
15. Concomitant weekly cisplatin and radiotherapy for head and neck cancer.
Homma A; Inamura N; Oridate N; Suzuki S; Hatakeyama H; Mizumachi T; Kano S; Sakashita T; Onimaru R; Yasuda K; Shirato H; Fukuda S
Jpn J Clin Oncol; 2011 Aug; 41(8):980-6. PubMed ID: 21715362
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
[TBL] [Abstract][Full Text] [Related]
17. Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings?
Valentini V; Massaccesi M; Balducci M; Mantini G; Micciché F; Mattiucci GC; Dinapoli N; Meduri B; D'Agostino GR; Salvi G; Nardone L
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):535-9. PubMed ID: 19540061
[TBL] [Abstract][Full Text] [Related]
18. [Chemo- and radiotherapy of patients with different types of malignant neoplasms].
Aliev BM
Med Radiol (Mosk); 1986 Jun; 31(6):11-4. PubMed ID: 3523097
[No Abstract] [Full Text] [Related]
19. A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.
Seiwert TY; Connell PP; Mauer AM; Hoffman PC; George CM; Szeto L; Salgia R; Posther KE; Nguyen B; Haraf DJ; Vokes EE
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):515-22. PubMed ID: 17255273
[TBL] [Abstract][Full Text] [Related]
20. Irinotecan, cisplatin, and radiation in esophageal cancer.
Ilson DH; Minsky B; Kelsen D
Oncology (Williston Park); 2002 May; 16(5 Suppl 5):11-5. PubMed ID: 12109799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
